Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Potkin

Showing results (31-40 of 217) with videos related to

Pageof 22
Sort By:
Schizophrenia Research|February 13, 2019
Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label studyBrian J Miller, Amy Claxton, Yangchun Du, et al.
Drugs & Aging|April 13, 2006
A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementiaSteven G Potkin, Gus Alva, Ibrahim Gunay, et al.
The Journal of Clinical Psychiatry|January 30, 2019
Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention TrialChristoph U Correll, Steven G Potkin, Yan Zhong, et al.
Neuroinformatics|July 18, 2006
A general XML schema and SPM toolbox for storage of neuro-imaging results and anatomical labelsDavid Bryant Keator, Syam Gadde, Jeffrey S Grethe, et al.
Brain Research|September 17, 2002
Brain metabolic effects of Neotrofin in patients with Alzheimer's diseaseSteven G Potkin, Gustavo Alva, David Keator, et al.
Neuroreport|April 3, 2008
Multivariate analyses suggest genetic impacts on neurocircuitry in schizophreniaEmanuela Tura, Jessica A Turner, James H Fallon, et al.
Synapse (New York, N.Y.)|October 28, 2006
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competitionBalasubramaniam Easwaramoorthy, Rama Pichika, Daphne Collins, et al.
Current Medical Research and Opinion|December 23, 2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitorsSerge Gauthier, Murat Emre, Martin R Farlow, et al.
Journal of Psychiatric Research|August 12, 2011
Assessment of psychological pain in major depressive episodesSteven Mee, Blynn G Bunney, William E Bunney, et al.
The Journal of Clinical Psychiatry|October 6, 2007
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation studyAntony D Loebel, Sumant Khanna, Sunita Rajadhyaksha, et al.
Pageof 22

Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
Schizophrenia Research|February 13, 2019
Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label studyBrian J Miller, Amy Claxton, Yangchun Du, et al.
Drugs & Aging|April 13, 2006
A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementiaSteven G Potkin, Gus Alva, Ibrahim Gunay, et al.
The Journal of Clinical Psychiatry|January 30, 2019
Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention TrialChristoph U Correll, Steven G Potkin, Yan Zhong, et al.
Neuroinformatics|July 18, 2006
A general XML schema and SPM toolbox for storage of neuro-imaging results and anatomical labelsDavid Bryant Keator, Syam Gadde, Jeffrey S Grethe, et al.
Brain Research|September 17, 2002
Brain metabolic effects of Neotrofin in patients with Alzheimer's diseaseSteven G Potkin, Gustavo Alva, David Keator, et al.
Neuroreport|April 3, 2008
Multivariate analyses suggest genetic impacts on neurocircuitry in schizophreniaEmanuela Tura, Jessica A Turner, James H Fallon, et al.
Synapse (New York, N.Y.)|October 28, 2006
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competitionBalasubramaniam Easwaramoorthy, Rama Pichika, Daphne Collins, et al.
Current Medical Research and Opinion|December 23, 2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitorsSerge Gauthier, Murat Emre, Martin R Farlow, et al.
Journal of Psychiatric Research|August 12, 2011
Assessment of psychological pain in major depressive episodesSteven Mee, Blynn G Bunney, William E Bunney, et al.
The Journal of Clinical Psychiatry|October 6, 2007
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation studyAntony D Loebel, Sumant Khanna, Sunita Rajadhyaksha, et al.
Pageof 22